Paper9529600
Functions of the BRCA1 and BRCA2 genes.
Bertwistle D and 1 other. Curr Opin Genet Dev, 1998. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Functions of the BRCA1 and BRCA2 genes. Papers, record 9529600. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9529600
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BRCA1 Protein | Major topic |
| Neoplasm Proteins | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| BRCA2 Protein | |
| DNA Repair | |
| Humans | |
| Neoplasms | |
| Transcription, Genetic |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37351713 | Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations. | Discov Oncol | 2023 | https://conductscience.org/library/papers/37351713 | PubMed |
| 33390797 | Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33390797 | PubMed |
| 26840090 | CRISPR/Cas9 and cancer targets: future possibilities and present challenges. | Oncotarget | 2016 | https://conductscience.org/library/papers/26840090 | PubMed |
| 24591761 | Molecular markers for breast cancer: prediction on tumor behavior. | Dis Markers | 2014 | https://conductscience.org/library/papers/24591761 | PubMed |
| 24371431 | Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer. | Breast Cancer Online | 2005 | https://conductscience.org/library/papers/24371431 | PubMed |
| 23674270 | BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study. | Genet Epidemiol | 2013 | https://conductscience.org/library/papers/23674270 | PubMed |
| 23552402 | DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients. | Oncogenesis | 2012 | https://conductscience.org/library/papers/23552402 | PubMed |
| 20510205 | Fine tuning chemotherapy to match BRCA1 status. | Biochem Pharmacol | 2010 | https://conductscience.org/library/papers/20510205 | PubMed |
| 19901968 | A 'DNA replication' signature of progression and negative outcome in colorectal cancer. | Oncogene | 2010 | https://conductscience.org/library/papers/19901968 | PubMed |
| 17145718 | Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/17145718 | PubMed |
| 16417649 | New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines. | Breast Cancer Res | 2006 | https://conductscience.org/library/papers/16417649 | PubMed |
| 16389418 | Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history. | Sao Paulo Med J | 2005 | https://conductscience.org/library/papers/16389418 | PubMed |
| 14647413 | Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression. | Oncogene | 2004 | https://conductscience.org/library/papers/14647413 | PubMed |
| 12947387 | Regulation and mechanisms of mammalian double-strand break repair. | Oncogene | 2003 | https://conductscience.org/library/papers/12947387 | PubMed |
| 11532935 | Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. | EMBO J | 2001 | https://conductscience.org/library/papers/11532935 | PubMed |
| 11494122 | Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice. | Oncogene | 2001 | https://conductscience.org/library/papers/11494122 | PubMed |
| 11313975 | Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. | Oncogene | 2001 | https://conductscience.org/library/papers/11313975 | PubMed |
| 11250682 | The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology? | Breast Cancer Res | 1999 | https://conductscience.org/library/papers/11250682 | PubMed |
| 11114888 | Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. | Genes Dev | 2000 | https://conductscience.org/library/papers/11114888 | PubMed |
| 10819537 | Developmental studies of Brca1 and Brca2 knock-out mice. | J Mammary Gland Biol Neoplasia | 1998 | https://conductscience.org/library/papers/10819537 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9529600
GET https://conductscience.org/api/papers/v1/9529600/cited_by?page=2